2R2: Higher Dose Rifampin for 2 Months vs Standard Dose Rifampin for Latent TB.

Clinical trial NCT03988933 · COMPLETED

Trial details

NCT number: NCT03988933
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Latent Tuberculosis

Start date: 2019-09-20
Primary completion: 2023-01-31
Enrollment: 1368

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.